BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7560688)

  • 1. Aminoglycosides lower serum magnesium concentrations in patients with cystic fibrosis: a retrospective study.
    Holben DH; Smith AM; Wilmott RW
    J Am Diet Assoc; 1995 Oct; 95(10):1152-4. PubMed ID: 7560688
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypomagnesaemia in cystic fibrosis patients referred for lung transplant assessment.
    Gupta A; Eastham KM; Wrightson N; Spencer DA
    J Cyst Fibros; 2007 Sep; 6(5):360-2. PubMed ID: 17412651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin A, provitamin A and vitamin E serum concentrations in cystic fibrosis patients.
    Bui MH
    Int J Vitam Nutr Res; 1988; 58(3):354-5. PubMed ID: 3198325
    [No Abstract]   [Full Text] [Related]  

  • 4. A retrospective analysis using Monte Carlo simulation to evaluate recommended ceftazidime dosing regimens in healthy volunteers, patients with cystic fibrosis, and patients in the intensive care unit.
    Mouton JW; Punt N; Vinks AA
    Clin Ther; 2005 Jun; 27(6):762-72. PubMed ID: 16117983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case-control study of acute renal failure in patients with cystic fibrosis in the UK.
    Smyth A; Lewis S; Bertenshaw C; Choonara I; McGaw J; Watson A
    Thorax; 2008 Jun; 63(6):532-5. PubMed ID: 18245146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensorineural hearing loss in patients with cystic fibrosis.
    Cheng AG; Johnston PR; Luz J; Uluer A; Fligor B; Licameli GR; Kenna MA; Jones DT
    Otolaryngol Head Neck Surg; 2009 Jul; 141(1):86-90. PubMed ID: 19559964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapatient variation in aminoglycoside disposition in cystic fibrosis.
    Bosso JA; Relling MV; Townsend PL; Strand LM
    Clin Pharm; 1987 Jan; 6(1):54-8. PubMed ID: 3816108
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved survival among young patients with cystic fibrosis.
    Kulich M; Rosenfeld M; Goss CH; Wilmott R
    J Pediatr; 2003 Jun; 142(6):631-6. PubMed ID: 12838190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis.
    Rosenfeld M; Gibson R; McNamara S; Emerson J; McCoyd KS; Shell R; Borowitz D; Konstan MW; Retsch-Bogart G; Wilmott RW; Burns JL; Vicini P; Montgomery AB; Ramsey B
    J Pediatr; 2001 Oct; 139(4):572-7. PubMed ID: 11598606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.
    van Ewijk BE; van der Zalm MM; Wolfs TF; Fleer A; Kimpen JL; Wilbrink B; van der Ent CK
    Pediatrics; 2008 Dec; 122(6):1171-6. PubMed ID: 19047230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term study of patients with cystic fibrosis.
    Anderson CM
    Bibl Paediatr; 1967; 86():342-9. PubMed ID: 4964166
    [No Abstract]   [Full Text] [Related]  

  • 13. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients.
    Fluge G; Olesen HV; Gilljam M; Meyer P; Pressler T; Storrösten OT; Karpati F; Hjelte L
    J Cyst Fibros; 2009 May; 8(3):198-202. PubMed ID: 19303374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quality of life of children with cystic fibrosis].
    Jiménez Hernández JL; Vázquez Cordero C; López Peña P; Oteiza Motrico A
    An Esp Pediatr; 1993 Nov; 39(5):415-8. PubMed ID: 8285454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antineutrophil cytoplasmic antibodies in cystic fibrosis. Frequency and significance].
    Berlie I; Leboucher B; Leblanc M; Troussier F; Pellier I; Chevailler A; Giniès JL
    Arch Pediatr; 2005 Feb; 12(2):140-3. PubMed ID: 15694536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
    Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
    Fennell PB; Quante J; Wilson K; Boyle M; Strunk R; Ferkol T
    J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reduced concentration of insulin-like growth factor I in patients with cystic fibrosis].
    Laursen EM; Juul A; Thorsteinsson SL; Høiby N; Koch C; Müller JR; Skakkebaek NE
    Ugeskr Laeger; 1996 Sep; 158(38):5300-2. PubMed ID: 8966779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.